3IQQ
X-ray structure of bovine TRTK12-Ca(2+)-S100B
Summary for 3IQQ
| Entry DOI | 10.2210/pdb3iqq/pdb |
| Descriptor | Protein S100-B, TRTK12 peptide, CapZ protein, CALCIUM ION, ... (4 entities in total) |
| Functional Keywords | ef hand, alpha helical, metal-binding, nucleus, metal binding protein |
| Biological source | Bos taurus (bovine) More |
| Cellular location | Cytoplasm: P02638 |
| Total number of polymer chains | 2 |
| Total formula weight | 12239.86 |
| Authors | Charpentier, T.H.,Weber, D.J.,Toth, E.A. (deposition date: 2009-08-20, release date: 2010-02-02, Last modification date: 2023-09-06) |
| Primary citation | Charpentier, T.H.,Thompson, L.E.,Liriano, M.A.,Varney, K.M.,Wilder, P.T.,Pozharski, E.,Toth, E.A.,Weber, D.J. The Effects of CapZ Peptide (TRTK-12) Binding to S100B-Ca(2+) as Examined by NMR and X-ray Crystallography J.Mol.Biol., 396:1227-1243, 2010 Cited by PubMed Abstract: Structure-based drug design is underway to inhibit the S100B-p53 interaction as a strategy for treating malignant melanoma. X-ray crystallography was used here to characterize an interaction between Ca(2)(+)-S100B and TRTK-12, a target that binds to the p53-binding site on S100B. The structures of Ca(2+)-S100B (1.5-A resolution) and S100B-Ca(2)(+)-TRTK-12 (2.0-A resolution) determined here indicate that the S100B-Ca(2+)-TRTK-12 complex is dominated by an interaction between Trp7 of TRTK-12 and a hydrophobic binding pocket exposed on Ca(2+)-S100B involving residues in helices 2 and 3 and loop 2. As with an S100B-Ca(2)(+)-p53 peptide complex, TRTK-12 binding to Ca(2+)-S100B was found to increase the protein's Ca(2)(+)-binding affinity. One explanation for this effect was that peptide binding introduced a structural change that increased the number of Ca(2+) ligands and/or improved the Ca(2+) coordination geometry of S100B. This possibility was ruled out when the structures of S100B-Ca(2+)-TRTK-12 and S100B-Ca(2+) were compared and calcium ion coordination by the protein was found to be nearly identical in both EF-hand calcium-binding domains (RMSD=0.19). On the other hand, B-factors for residues in EF2 of Ca(2+)-S100B were found to be significantly lowered with TRTK-12 bound. This result is consistent with NMR (15)N relaxation studies that showed that TRTK-12 binding eliminated dynamic properties observed in Ca(2+)-S100B. Such a loss of protein motion may also provide an explanation for how calcium-ion-binding affinity is increased upon binding a target. Lastly, it follows that any small-molecule inhibitor bound to Ca(2+)-S100B would also have to cause an increase in calcium-ion-binding affinity to be effective therapeutically inside a cell, so these data need to be considered in future drug design studies involving S100B. PubMed: 20053360DOI: 10.1016/j.jmb.2009.12.057 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.01 Å) |
Structure validation
Download full validation report






